Elena Klenova is a scientist with almost 40 years of experience in research who published more than 70 scientific papers. Elena Klenova graduated from the Lomonosov Moscow State University and began her scientific career at the Institute of General Genetics in Moscow (Former Soviet Union), where she later obtained a PhD. She then worked at the All-Union Cancer Research Centre in Moscow. In 1990 Elena moved to the UK to work on a novel transcription factor, CTCF, at the Institute of Cancer Research in London and later at the University of Oxford. CTCF and a related protein, BORIS, have now become the focus of modern research into the organization and function of the nucleus of eukaryotic cells. Elena joined University of Essex in 2001, where she continued her studies on functional roles of CTCF and BORIS in normal development and disease, and initiated new projects related to discovery and characterization of cancer biomarkers. Elena worked in close collaboration with the clinicians on the translational aspects of her research. She retired from her position as Professor of Molecular Oncology at the University of Essex in 2020, but she is associated with the University as Professor Emeritus and still involved in cancer research.